We present a unique case of a 42-year-old gentleman with newly diagnosed Graves’ disease and isolated right ventricular failure. Extensive evaluation to include echocardiogram and cardiac catheterization were negative for significant pulmonary hypertension or coronary artery disease as potential etiologies. Hyperthyroid induced vasospasm is a rare but reported clinical entity that serves to be a clinical and diagnostic dilemma.
Coronary artery, vasospasm, hyperthyroidism, ventricular failure.
Ahmad M. Slim, Cardiology Service, MCHE-MDC, 3851 Roger Brooke Drive, Brooke Army Medical Center, Fort Sam Houston, TX, USA. Tel: +1.78234.6200; +1.210.916-5451 – Fax: +1.210.916-3051. E-mail: firstname.lastname@example.org
Share this Article
Related Content In Heart Failure
49/Multi-disciplinary heart failure- Device clinic improves management of heart failure patients following complex device implantatio
European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr49
Introduction: Complex device therapy (CDT) [cardiac resynchronisation therapy pacemaker or defibrillator (CRTP or CRTD) and implantable cardioverter defibrillator (ICD)], is recommended in patients with heart failure (HF) with severe left ventricular systolic dysfunction if they are still symptomatic despite optimisation HF medication. Several patients however, will only tolerate optimal doses of these drugs after CDT, […]
47/Association between very high NT-proBNP levels, and haemoglobin and ferritin
European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr47
Introduction: The adverse prognosis in heart failure (HF) correlates with both NT-proBNP and high-sensitivity CRP levels. The latter indicates a greater underlying inflammatory process in more severe heart failure. This inflammatory response is also evidenced by elevated ferritin (acute phase reactant) and reduced haemoglobin (bone marrow suppression) amongst these patients. It is unclear if there […]
Management of Atrial Fibrillation in Recipients of Cardiac Resynchronization Therapy
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):19-25 DOI: https://doi.org/10.17925/EJAE.2021.7.1.19
Atrial fibrillation (AF) and heart failure (HF) often co-exist. The incidence of AF is estimated to reach 45% of patients with HF and rises with the severity of HF symptoms, from about 5% of patients in the New York Heart Association (NYHA) class I to 50% in NYHA class IV.1–4 Consistently, the incidence of AF […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!